Allarity Therapeutics, Inc. - ALLR

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.389M
QoQ value delta ($000)
-$238K (-14.63%)
Implied price effect (QoQ)
-31.74%
Shares
Total shares
1,292,104
QoQ shares delta
+258,914 (+25.06%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ALLR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 20 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
RENAISSANCE TECHNOLOGIES LLC 267 247,612 0.0%
VANGUARD GROUP INC 266 246,708 0.0%
GEODE CAPITAL MANAGEMENT, LLC 169 156,640 0.0%
STATE STREET CORP 148 137,600 0.0%
DRW Securities, LLC 132 122,741 0.0%
CAPITAL ADVISORS INC/OK 108 100,000 0.0%
CITADEL ADVISORS LLC 91 84,591 0.0%
Private Advisor Group, LLC 59 55,536 0.0%
XTX Topco Ltd 36 33,644 0.0%
NORTHERN TRUST CORP 31 28,942 0.0%
TWO SIGMA INVESTMENTS, LP 29 27,492 0.0%
UBS Group AG 28 26,516 0.0%
TWO SIGMA SECURITIES, LLC 14 13,594 0.0%
HRT FINANCIAL LP 11 10,347 0.0%
BANK OF AMERICA CORP /DE/ 0 140 0.0%
DANSKE BANK A/S 0 1 0.0%